Evaluation of imaging biomarker by transgenic mouse models

Japanese Journal of Neuropsychopharmacology

Volumn 29, Issue 2, 2009, Pages 73-78

  Maeda, Jun ^a   Higuchi, Makoto ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

amyloid; II type calcium calumodulin dependent protein kinase ; Positron emission tomography; Transgenic mouse

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

AGGRESSION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; CONTROLLED STUDY; KNOCKOUT MOUSE; MENTAL DISEASE; MOOD DISORDER; MOUSE; NONHUMAN; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BIOLOGICAL MARKERS; BRAIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOOD DISORDERS; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 67651030978     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. 1A receptors in animal and human brain. Neuropharmacology, 52: 695-707. (Pubitemid 46227474)
2. Chen, C., Rainnie, D. G., Greene, R. W. and Tonegawa, S. (1994) Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science, 266: 291-294. (Pubitemid 24343517)
3. Hosoda, R., Saido, T. C., Otvos, L. Jr, Arai, T., Mann, D. M., Lee, V. M., Trojanowski, J. Q. and Iwatsubo, T. (1998) Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains. J Neuropathol Exp Neurol, 57: 1089-1095. (Pubitemid 28525456)
4. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G.. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science, 274: 99-102.
5. 11C] (+) McN5652. Biol Psychiatry, 51: 715-722.
6. Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.R., Suzuki, K., Ando, K., Staufenbiel, M., Trojanowski, J. Q., Lee, V. M., Higuchi, M. and Suhara, T. (2008) Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J Neurosci, 28: 12255-12267.
7. Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G. F., Estrada, S., Ausén, B., Debnath, M. L., Barletta, J., Price, J. C., Sandell, J., Lopresti, B. J., Wall, A., Koivisto, P., Antoni, G., Mathis, C. A. and Långström B. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol, 55: 306-319. (Pubitemid 38269583)
8. Klunk, W. E., Lopresti, B. J., Ikonomovic, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., Debnath, M. L., Holt, D. P., Huang, G. F., Shao, L., DeKosky, S. T., Price, J. C. and Mathis, C. A. (2005) Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci, 25: 10598-10606. (Pubitemid 41681907)
9. 11C] WAY-100635: Effect of endogenous serotonin. Synapse, 40: 122-129.
10. 11C] DAA1106 for PET: An imaging tool for glial cells in the brain. Synapse, 52: 283-291.
11. Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., Suzuki, K., Mori, H., Higuchi, M. and Suhara, T. (2007a) Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci, 27: 10957-10968. (Pubitemid 47574168)
12. Maeda, J., Higuchi, M., Inaji, M., Ji, B., Haneda, E., Okauchi, T., Zhang, M. R., Suzuki, K. and Suhara, T. (2007b) Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res, 1157: 100-111. (Pubitemid 46935074)
13. Price, J. L. and Morris, J. C. (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol, 45: 358-368.
14. Saido, T. C., Iwatsubo, T., Mann, D. M., Shimada, H., Ihara, Y. and Kawashima, S. (1995) Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3 (pE), in senile plaques. Neuron, 14: 457-466.
15. Schilling, S., Zeitschel, U., Hoffmann, T., Heiser, U., Francke, M., Kehlen, A., Holzer, M., Hutter-Paier, B., Prokesch, M., Windisch, M., Jagla, W., Schlenzig, D., Lindner, C., Rudolph, T., Reuter, G., Cynis, H., Montag, D., Demuth, H. U. and Rossner, S. (2008) Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med, 14: 1106-1111.
16. Silva, A. J., Stevens, C. F., Tonegawa, S. and Wang, Y. (1992) Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science, 257: 201-206.
17. Suhara, T, Okubo, Y, Yasuno, F, Sudo, Y, Inoue, M, Ichimiya, T, Nakashima, Y, Nakayama, K, Tanada, S, Suzuki, K, Halldin, C. and Farde, L. (2002) Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry, 59: 25-30. (Pubitemid 34044401)
18. Suhara, T., Takano, A., Sudo, Y., Ichimiya, T., Inoue, M., Yasuno, F., Ikoma, Y. and Okubo, Y. (2003) High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Arch Gen Psychiatry, 60: 386-391. (Pubitemid 36402999)
19. Tai, Y. C., Ruangma, A., Rowland, D., Siegel, S., Newport, D. F., Chow, P. L. and Laforest, R. (2007) Performance evaluation of the microPET focus: A third-generation microPET scanner dedicated to animal imaging. J Nucl Med, 46: 455-463.
20. Takao, K., Yamasaki, N. and Miyakawa, T. (2007) Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatrie disorders. Neurosci Res, 58: 124-132. (Pubitemid 46843324)
21. 11C] 6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imaging, 32: 593-600. (Pubitemid 41214203)
22. Yamasaki, N., Maekawa, M., Kobayashi, K., Kajii, Y., Maeda, J., Soma, M., Takao, K., Tanda, K., Ohira, K., Toyama, K., Kanzaki, K., Fukunaga, K., Sudo, Y., Ichinose, H., Ikeda, M., Iwata, N., Ozaki, N., Suzuki, H., Higuchi, M., Suhara, T., Yuasa, S. and Miyakawa, T. (2008) Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain, 1: 6.
23. Yanamoto, K., Zhang, M. R., Kumata, K., Hatori, A., Okada, M. and Suzuki, K. (2007) In vitro and ex vivo autoradiography studies on peripheral-type benzodiazepine receptor binding using [11C] AC-5216 in normal and kainic acid-lesioned rats. Neurosci Lett, 428: 59-63.
24. Yasuno, F., Suhara, T., Okubo, Y., Sudo, Y., Inoue, M., Ichimiya, T. and Tanada, S. (2001) Dose relationship of limbic-cortical D2-dopamine receptor occupancy with risperidone. Psychopharmacology (Berl), 154: 112-114. (Pubitemid 32186522)
25. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S. M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q. and Lee, V. M. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron, 53: 337-351. (Pubitemid 46161268)
26. 18F] fluoroethyl-5-methoxybenzyl) acetamide, for PET imaging of peripheral benzodiazepine receptor in primate brain. J Med Chem, 47: 2228-2235. (Pubitemid 38478846)
27. 11C-AC-5216: A novel PET ligand for peripheral benzodiazepine receptors in the primate brain. J Nucl Med, 48: 1853-1861. (Pubitemid 350099332)